IP Library Granted Patent US 12,544,584
Granted Patent B2
US 12,544,584 · App. 17/228,292 · Granted Feb 10, 2026

Therapeutic lighting devices and methods

Inventors: Mikiya Silver (New Haven, CT); Gennady Kleyman (Brooklyn, NY); Vinod V. Pathy (Shelton, CT)
Assignee: Pathy Medical, LLC
A61N5/06A61B17/02A61B2018/00595A61B2018/00922A61B2018/1412A61B2090/309A61N2005/0626A61N2005/0644A61N2005/0651A61N2005/0659A61N2005/0661A61N2005/0662A61N2005/0664A61N5/067
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,544,584
App. No.
17/228,292
Granted
Feb 10, 2026
Kind
B2
Abstract

A device for treating biological tissue including a body having opposed proximal and distal end portions, a shroud extending from the distal end portion of the body, and a light source supported at a distal end of the body and connected to a power source for emitting therapeutic light to treat biological tissue proximate to the shroud, wherein the shroud is dimensioned and configured to establish an effective distance and area of therapeutic light treatment relative to the biological tissue to be treated.

Claims (23)

1 . A device for treating biological tissue, comprising:

a) a body having opposed proximal and distal end portions;

b) a shroud extending from the distal end portion of the body for establishing an effective distance and an area of therapeutic treatment relative to biological tissue to be treated, wherein the shroud is fixedly fastened to the body so that the effective distance relative to the biological tissue to be treated is a fixed distance;

c) a light source supported at a distal end of the body and connected to a power source for emitting therapeutic light to treat the biological tissue within the effective area of therapeutic treatment, wherein the light source includes a printed circuit board (PCB) supported within the distal end portion of the body and having a plurality of LED light sources embedded thereon, and wherein a planar lens is supported within the distal end portion of the body in front of the plurality of LED light sources for focusing the therapeutic light to the area of therapeutic treatment, and

d) electro-mechanical means operatively associated with the body and the shroud configured to automatically activate the power source and/or the light source when the shroud comes into contact with the biological tissue to be treated.

2 . The device as recited in claim 1 , wherein the power source is housed within an interior cavity of the body or it is housed external to the body.

3 . The device as recited in claim 1 , wherein the therapeutic light is selected from a group of light sources consisting of UV light, UV-C light, Far UV-C light, infrared light, near infrared light, low level laser light and White light.

4 . The device as recited in claim 1 , wherein a switch is operatively associated with the body for activating the power source and/or the light source.

5 . The device as recited in claim 1 , wherein a control circuit is operatively associated with the printed circuit board so that the power source and/or light source can be deactivated after a predetermined treatment period or provide an indication to a user that the treatment period has been completed.

6 . The device as recited in claim 1 , wherein the shroud is formed from a material that is impervious to the therapeutic light so as to avoid an impact of the therapeutic light on areas of the biological tissue that are not intended to be treated.

7 . The device as recited in claim 1 , wherein the power source is remote from the body and it is connected to the light source by an electrical wire.

8 . The device as recited in claim 1 , wherein indicator means are associated with the printed circuit board for sonically or visually indicating when the power source has been deactivated or providing an indication to a user that the treatment has been completed.

9 . The device as recited in claim 1 , wherein the light source comprises at least one laser diode supported within the body.

10 . The device as recited in claim 1 , wherein the PCB is rectangular, and wherein the plurality of LED light sources embedded on the PCB are arranged along a longitudinal axis of the PCB, wherein the planar lens extends along an axial length of the PCB and is co-planar with the PCB.

11 . A device for treating biological tissue, comprising:

a) a body having opposed proximal and distal end portions;

b) a shroud extending from the distal end portion of the body for establishing a minimum effective distance and an area of therapeutic treatment relative to biological tissue to be treated, wherein the shroud is fixedly fastened to the body so that the minimum effective distance relative to the biological tissue to be treated is a fixed distance defining a fixed volume therein where the biological tissue to be treated, the shroud, and a distal end of the body form the boundaries of the fixed volume;

c) a light source supported at the distal end of the body and connected to a power source for emitting therapeutic light to treat the biological tissue within the effective area of therapeutic treatment, and

d) electro-mechanical means operatively associated with the body and the shroud configured to automatically activate the light source when the electro-mechanical means comes into contact with the biological tissue to be treated, while the distal end of the body and light source remain at the fixed distance from the biological tissue to be treated.

12 . The device as recited in claim 11 , further comprising an indicator for sonically or visually indicating when the power source has been activated and/or the light source has been activated or provide an indication to a user that the treatment has begun.

13 . The device as recited in claim 12 , further comprising an indicator for sonically or visually indicating when the power source has been deactivated or provide an indication to the user that the treatment has been completed.

14 . The device as recited in claim 11 , wherein the electro-mechanical means includes an elongated probe extending from the distal end portion of the body configured to contact the biological tissue to be treated, wherein the probe is configured to automatically activate the light source when the probe comes into contact with the biological tissue to be treated.

15 . The device as recited in claim 14 , wherein the elongated probe extends beyond the shroud.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2021
From: SILVER, MIKIYA; KLEYMAN, GENNADY; PATHY, VINOD V.
To: PATHY MEDICAL, LLC
Reel/Frame 056125/0841 →
Continuity (2)
Provisional Application 63010950 · Apr 16, 2020
Related Publication 20210322782A1 · Oct 21, 2021
References Cited (26)
US 5871522A · Sentilles · 1999 [cited by examiner]
US 11147984B2 · Emerson · 2021 [cited by examiner]
US 20030181893A1 · Neuberger · 2003 [cited by examiner]
US 20060167531A1 · Gertner et al. · 2006 [cited by applicant]
US 20080077204A1 · Bornstein · 2008 [cited by examiner]
US 20090143842A1 · Cumbie · 2009 [cited by examiner]
US 20100094265A1 · Rastegar et al. · 2010 [cited by applicant]
US 20110040358A1 · Bean et al. · 2011 [cited by applicant]
US 20110288617A1 · Sharma · 2011 [cited by examiner]
US 20130013032A1 · Irwin · 2013 [cited by examiner]
US 20140005756A1 · Liu et al. · 2014 [cited by applicant]
US 20150112411A1 · Beckman et al. · 2015 [cited by applicant]
US 20160016001A1 · Loupis et al. · 2016 [cited by applicant]
US 20160166848A1 · Bouboulis · 2016 [cited by applicant]
US 20170136257A1 · Jurna et al. · 2017 [cited by applicant]
US 20180185526A1 · Brown · 2018 [cited by examiner]
US 20180318034A1 · Julian Ibanez et al. · 2018 [cited by applicant]
US 20190015681A1 · Pyun et al. · 2019 [cited by applicant]
US 20200230435A1 · Bae · 2020 [cited by examiner]
US 20210267436A1 · Yamashita · 2021 [cited by examiner]
CN 202288372U · 2012 [cited by applicant]
KR 1020120012194A · 2012 [cited by applicant]
KR 101168044B1 · 2012 [cited by applicant]
PCT International Search Report and Written Opinion dated Jul. 30, 2021, issued during the prosecution of PCT International Patent application No. PCT/US2021/027002. [cited by applicant]
Extended European Search Report issued by the European Patent Office, dated Jun. 14, 2024, in corresponding European Patent Application No. 21789121.7. [cited by applicant]
Canadian Office Action dated May 1, 2025, issued during the prosecution of CA 3173195. [cited by applicant]